MedTrace Logo

Stem Cell Therapy in Autism Spectrum Disorders

NCT01974973 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2018-10-25

No results posted yet for this study

Summary

The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with autism spectrum disorders

Conditions

  • Autism Spectrum Disorders

Interventions

PROCEDURE

Autologous bone marrow mononuclear cell transplantation

Intrathecal autologous bone marrow mononuclear cell transplantation

Sponsors & Collaborators

  • Neurogen Brain and Spine Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2016-01-31
Completion
2016-05-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01974973 on ClinicalTrials.gov